Cathie Wood Is Selling These 5 Stocks

2. Gamida Cell Ltd. (NASDAQ:GMDA)

Gamida Cell is an Israel-based clinical-stage biopharmaceutical company that develops cell therapies to cure blood cancers and serious hematologic diseases. Cathie Wood had owned a stake worth about $1.6 million in the company as of the end of the second quarter. This stake was sold during the third quarter.

In September, Gamida Cell Ltd. (NASDAQ:GMDA) revealed that its stem cell therapy candidate omidubicel led to clinical benefit at three years in a group of patients with blood cancer who typically have a poor prognosis.

As of the end of the second quarter, 5 hedge funds tracked by Insider Monkey had stakes in the company, compared to 9 funds in the previous quarter. Kris Jenner, Gordon Bussard and Graham Mcphail’s Rock Springs Capital Management was the biggest stakeholder of the company at the end of June with a $3.9 million stake.

Follow Gamida Cell Ltd. (NASDAQ:GMDA)